HIV ‐negative primary effusion lymphoma: a series of seven cases
Histopathology · 2025
DOI: 10.1111/his.15446 ↗Kurz gefasst
Fachartikel in der Zeitschrift Histopathology, 2025. Verfasst von Chang-Yao Chu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan. Hauptthemen laut MEDLINE: Lymphoma, Primary Effusion. Die Arbeit nennt 32 Literaturangaben. Gefördert von: National Science and Technology Council, Taiwan.
Abstract (Originalsprache)
Aims
Primary effusion lymphoma (PEL) is a rare aggressive, human herpesvirus‐8 (HHV8)‐associated neoplasm of post‐germinal centre B cell origin. It usually presents as a serous effusion in human immunodeficiency virus (HIV)‐positive patients. PEL is rarely reported in HIV‐negative patients. Methods and results wWe report seven cases of HIV‐negative elderly men diagnosed with PEL in a single institution. Clinical information and laboratory characteristics were collected. All patients were men, with a mean age of 76 years (range = 60–93) and presented with pleural effusions ( n = 6), pericardial effusion ( n = 1) and/or ascites ( n = 2); two patients had multiple effusions. Extracavitary tissue involvement was present in one patient, who was also a liver transplant recipient. All patients had a decreased blood lymphocyte fraction, with a zero CD4+ count in one. The tumour cells in cytology of effusions showed a moderate amount of cytoplasm, perinuclear hof (a focal area of clearing) and irregular nuclear outlines with coarse chromatin and prominent nucleoli. Immunohistochemically, PEL cells were positive for HHV8 latent nuclear antigen (7 of 7), CD45 (3 of 3), CD30 (4 of 4), MUM1/IRF4 (2 of 2) and were negative for CD3 and CD20 in all seven cases. CD138 was positive in six of seven cases. Epstein–Barr virus (EBV) was detected in two of seven cases by in‐situ hybridisation. B cell clonality by polymerase chain reaction (PCR) was positive in two cases with adequate materials available. Conventional cytogenetic analysis showed complex karyotypes in three of five cases, with recurrent +8, +12 and t(4;12)(q27;q21), and one case with +7. Six of seven patients died of disease with a mean survival of 5.4 months (range = 0.4–11.2 months).
Conclusions
PEL can arise in immunocompetent, older patients, in this series all men, and behaves aggressively. These neoplasms are similar to their HIV‐positive counterparts with anaplastic cytomorphology, HHV8 infection and a plasmablastic immunophenotype. The aetiology of PEL is uncertain, but may be related to physiological immunodeficiency associated with ageing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan.
- School of Medicine, College of Medicine, National Sun Yat-Sen University, Kaohsiung, Taiwan.
- Department of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng, Kung University, Tainan, Taiwan.
- Naokon Diagnostics, Imphal, Manipur, India.
- Division of Hematology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng, Kung University, Tainan, Taiwan.
- Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
ORCID-Profile: L Jeffrey Medeiros, Kung-Chao Chang
Förderung
- National Science and Technology Council, Taiwan
Zitieren
APA
Chu, C. Y., Thingujam, B., Wang, S. H., Chen, Y. P., Cheng, H. Y., Medeiros, L. J., & Chang, K. C. (2025). HIV ‐negative primary effusion lymphoma: a series of seven cases. Histopathology. https://doi.org/10.1111/his.15446
Vancouver
Chu CY, Thingujam B, Wang SH, Chen YP, Cheng HY, Medeiros LJ, et al. HIV ‐negative primary effusion lymphoma: a series of seven cases. Histopathology. 2025. doi:10.1111/his.15446
BibTeX
@article{Chu2025,
author = {Chu, Chang-Yao and Thingujam, Bipin and Wang, Shu-Hsien and Chen, Ya-Ping and Cheng, Hsueh-Yin and Medeiros, L Jeffrey and Chang, Kung-Chao},
title = {HIV ‐negative primary effusion lymphoma: a series of seven cases},
journal = {Histopathology},
year = {2025},
doi = {10.1111/his.15446}
}
EUVIMED